Biopterin. VII. Inhibition of synthesis of reduced biopterins and its bearing on the function of cerebral tryptophan-5-hydroxylase in vivo.
Repeated intraventricular injections of 2,4-diamino-6-hydroxypyrimidine (DAO-Pyr), inhibitor of D-erythro-q-dihydroneopterin triphosphate synthetase, inhibited q-BH2 synthesis from GTP, markedly increased accumulation of 2-amino-4-hydroxy-5 (or -6)-formamido-6-triphosphoribosylaminopyrimidine (FPyd-P3) and brought about a 60% decrease in the in vivo of reduced biopterin (BH2 and BH4) pool in the brain. Nevertheless, there was no effect on the rate of hydroxylation of L-tryptophan or on the 5-hydroxytryptamine level in rat brain. These data emphasized the significance of the rate of hydrogen transfer and the limitation of the concept of "unsaturation" (i.e., the absolute amount of the carrier pterin molecule) for the synthesis of neurotransmitters in vivo.
D000818:Animals; D001708:Biopterins / Q000031:analogs & derivatives / Q000096:biosynthesis* / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D006160:Guanosine Triphosphate / Q000378:metabolism; D007042:Hypoxanthines / Q000494:pharmacology*; D011621:Pteridines / Q000096:biosynthesis* / Q000378:metabolism*; D011742:Pyrimidine Nucleotides / Q000378:metabolism; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014365:Tryptophan Hydroxylase / Q000378:metabolism*
C030286:2-amino-6-(5'-triphospho-2'-deoxyribosyl)amino-5-formamido-4-hydroxypyrimidine; D007042:Hypoxanthines; D011621:Pteridines; D011742:Pyrimidine Nucleotides; D001708:Biopterins; D012701:Serotonin; C017226:7,8-dihydrobiopterin; D006160:Guanosine Triphosphate; D014365:Tryptophan Hydroxylase; C017202:2,4-diaminohypoxanthine